Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SI7S
|
|||
| Former ID |
DNC009076
|
|||
| Drug Name |
5,6,7,8-tetrahydroanthracene-1,4-dione
|
|||
| Synonyms |
CHEMBL508233; 5,6,7,8-tetrahydroanthracene-1,4-dione; SCHEMBL11038167
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H12O2
|
|||
| Canonical SMILES |
C1CCC2=CC3=C(C=C2C1)C(=O)C=CC3=O
|
|||
| InChI |
1S/C14H12O2/c15-13-5-6-14(16)12-8-10-4-2-1-3-9(10)7-11(12)13/h5-8H,1-4H2
|
|||
| InChIKey |
DWXLNXHEUIUNRF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | M-phase inducer phosphatase 2 (MPIP2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Cell cycle | ||||
| Progesterone-mediated oocyte maturation | ||||
| MicroRNAs in cancer | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| TGF_beta_Receptor Signaling Pathway | ||||
| Wnt Signaling Pathway | ||||
| Pathway Interaction Database | PLK1 signaling events | |||
| FOXM1 transcription factor network | ||||
| p38 signaling mediated by MAPKAP kinases | ||||
| Aurora A signaling | ||||
| Reactome | Cyclin B2 mediated events | |||
| Cyclin A/B1 associated events during G2/M transition | ||||
| Cyclin A:Cdk2-associated events at S phase entry | ||||
| WikiPathways | Senescence and Autophagy in Cancer | |||
| MAPK Signaling Pathway | ||||
| Retinoblastoma (RB) in Cancer | ||||
| Prostate Cancer | ||||
| Integrated Breast Cancer Pathway | ||||
| Integrated Cancer pathway | ||||
| Mitotic G2-G2/M phases | ||||
| Cell Cycle | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases. Bioorg Med Chem. 2009 Mar 15;17(6):2276-81. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.